Concepedia

Author

Keiko Shinozawa

Tokyo Medical UniversityORCID

Also Known As

K Shinozawa, K. SHINOZAWA, K. Shinozawa, Keiko SHINOZAWA, Keiko Shinozawa

63

Publications

295

Citations

8

H-Index

12

Concepts

All Affiliations

Tokyo Medical UniversityNara Medical University
KS

About

Keiko Shinozawa is an author at Tokyo Medical University specializing in pathogenesis, genetics, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

29

2

Public Health

1

1

11

3

Epidemiology

1

1

11

4

Molecular Biology

1

1

18

5

Molecular Genetics

1

1

18

Keiko Shinozawa

×

8

Publications

194

Citations

8

H-Index

YearCitations

Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden

Keiji Nogami, Keiko Shinozawa, Kenichi Ogiwara,

Blood

2014

71

Identification and characterization of an adenine to guanine transition within intron 10 of the factor <scp>VIII</scp> gene as a causative mutation in a patient with mild haemophilia A

Hiroshi Inaba, Takatoshi Koyama, Keiko Shinozawa,

Haemophilia

2012

28

Identification of deep intronic individual variants in patients with hemophilia A by next‐generation sequencing of the whole factor VIII gene

Hiroshi Inaba, Keiko Shinozawa, Kagehiro Amano,

Research and Practice in Thrombosis and Haemostasis

2017

23

Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V

Koji Yada, Keiji Nogami, Keiko Shinozawa,

British Journal of Haematology

2018

20

Molecular characterization of 3 factor V mutations, R2174L, V1813M, and a 5-bp deletion, that cause factor V deficiency

Keiko Shinozawa, Kagehiro Amano, Takashi Suzuki,

International Journal of Hematology

2007

18

Spectrum of F8 Genotype and Genetic Impact on Inhibitor Development in Patients with Hemophilia A from Multicenter Cohort Studies (J-HIS) in Japan

Keiko Shinozawa, Koji Yada, Tetsuhito Kojima,

Thrombosis and Haemostasis

2020

12

[Characterization of a large deletion that leads to congenital factor XIII deficiency].

Manabu Otaki, Hiroshi Inaba, Keiko Shinozawa,

PubMed

2008

11

In vitro validation of chromogenic substrate assay for evaluation of surrogate FVIII-activity of emicizumab

Tomoko Yamaguchi, Keiko Shinozawa, Satoru Nagatoishi,

Thrombosis Research

2023

11

Page 1